Federal Data Hub › HRSA 340B · JSON
340B ID CAH171370-00
ParticipatingCritical Access Hospital
GOODLAND REGIONAL MEDICAL CENTER is a Critical Access Hospital enrolled in the federal 340B Drug Pricing Program in GOODLAND, KS. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 18 contract-pharmacy arrangement(s) (1 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ACCREDO HEALTH GROUP INC | TEMPE, AZ | 2019-10-01 | 2025-06-05 | 75292 |
| ACCREDO HEALTH GROUP INC | WARRENDALE, PA | 2019-10-01 | 2025-06-05 | 23041 |
| ACCREDO HEALTH GROUP INC | MEMPHIS, TN | 2019-10-01 | 2025-06-05 | 45979 |
| ACCREDO HEALTH GROUP, INC. | NEW CASTLE, DE | 2019-10-01 | 2025-06-05 | 26445 |
| ACCREDO HEALTH GROUP, INC. | ORLANDO, FL | 2019-10-01 | 2025-06-05 | 39194 |
| ACCREDO HEALTH GROUP, INC. | INDIANAPOLIS, IN | 2019-10-01 | 2025-06-05 | 51763 |
| ESI MAIL PHARMACY SERVICE | TEMPE, AZ | 2019-10-01 | 2025-06-05 | 75670 |
| EXPRESS SCRIPTS | SAINT LOUIS, MO | 2019-10-01 | 2025-06-05 | 61609 |
| EXPRESS SCRIPTS PHARMACY, INC. | WHITESTOWN, IN | 2019-10-01 | 2025-06-05 | 90880 |
| EXPRESS SCRIPTS PHARMACY, INC. | BURLINGTON, NJ | 2019-10-01 | 2025-06-05 | 92471 |
| GOODLAND MED ARTS PHARM | GOODLAND, KS | 2014-07-01 | 2026-03-31 | 63414 |
| ONCOMED THE ONCOLOGY PHARMACY OF BUFFALO | AMHERST, NY | 2019-10-01 | 2025-06-05 | 5970 |
| OPTUM PHARMACY 702, LLC | JEFFERSONVILLE, IN | 2019-10-01 | 2025-06-05 | 90281 |
| OPTUM PHARMACY 801, INC. | PHOENIX, AZ | 2019-10-01 | 2025-06-05 | 119478 |
| SINA DRUG LLC | LOUISVILLE, KY | 2019-10-01 | 2025-06-05 | 92134 |
| SINA DRUG LLC | NEW HYDE PARK, NY | 2019-10-01 | 2025-06-05 | 4147 |
| SORKIN'S RX LTD | NEW HYDE PARK, NY | 2019-10-01 | 2025-06-05 | 19662 |
| WAL-MART PHARMACY 10-2562 | GOODLAND, KS | 2014-07-01 | — | 6339 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.